Correlation Between Inhibrx and Nuvalent

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Nuvalent at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Nuvalent into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Nuvalent, you can compare the effects of market volatilities on Inhibrx and Nuvalent and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Nuvalent. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Nuvalent.

Diversification Opportunities for Inhibrx and Nuvalent

0.35
  Correlation Coefficient

Weak diversification

The 3 months correlation between Inhibrx and Nuvalent is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Nuvalent in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvalent and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Nuvalent. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvalent has no effect on the direction of Inhibrx i.e., Inhibrx and Nuvalent go up and down completely randomly.

Pair Corralation between Inhibrx and Nuvalent

Given the investment horizon of 90 days Inhibrx is expected to generate 1.12 times more return on investment than Nuvalent. However, Inhibrx is 1.12 times more volatile than Nuvalent. It trades about 0.07 of its potential returns per unit of risk. Nuvalent is currently generating about -0.33 per unit of risk. If you would invest  1,570  in Inhibrx on October 7, 2024 and sell it today you would earn a total of  45.00  from holding Inhibrx or generate 2.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibrx  vs.  Nuvalent

 Performance 
       Timeline  
Inhibrx 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Inhibrx are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental drivers, Inhibrx may actually be approaching a critical reversion point that can send shares even higher in February 2025.
Nuvalent 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nuvalent has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Inhibrx and Nuvalent Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibrx and Nuvalent

The main advantage of trading using opposite Inhibrx and Nuvalent positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Nuvalent can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvalent will offset losses from the drop in Nuvalent's long position.
The idea behind Inhibrx and Nuvalent pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm